Latent murine cytomegalovirus infection in macrophages

Virology

Volumn 227, Issue 1, 1997, Pages 168-179

  Pollock, Jessica L ^a   Presti, Rachel M ^a   Paetzold, Susanne ^a   Virgin IVth, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; LATENT VIRUS INFECTION; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMALIA; CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0031555629     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8303     Document Type: Article

References (53)

1. Austyn, J. M., and Gordon, S. (1981). F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
2. Bale, J. F., O'Neil, M. E., Giller, R., Perlman, S., and Koszinowski, U. (1987). Murine cytomegalovirus genomic material in marrow cells: Relation to altered leukocyte counts during sublethal infection of mice. J. Infect. Dis. 155, 207-212.
3. Bale, J. F. J., and O'Neil, M. E. (1989). Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice. J. Virol. 63, 2667-2673.
4. Ballas, Z. K., and Rasmussen, W. (1993). Lymphokine-activated killer cells. IL-4 induces an NK1.1+CD8α+β-TCR-αβB220+ lymphokine activated killer subset. J. Immunol. 150, 17-30.
5. Balthesen, M., Messerle, M., and Reddehase, M. J. (1993). Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67, 5360-5366.
6. Balthesen, M., Dreher, L., Lucin, P., and Reddehase, M. J. (1994). The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection. J. Gen. Virol. 75, 2329-2336.
7. Brautigam, A. R., Dutko, F. J., Olding, L. B., and Oldstone, M. B. (1979). Pathogenesis of murine cytomegalovirus infection: The macrophage as a permissive cell for cytomegalovirus infection, replication, and latency. J. Gen. Virol. 44, 349-359.
8. Britt, W. J., and Alford, C. A. (1996). In "Fields Virology" (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), 3rd ed., pp. 2493-2523. Lippincott-Raven, Philadelphia.
9. Busch, F. W., Mutter, W., Koszinowski, U. H., and Reddehase, M. J. (1991). Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma. J. Virol. 65, 981-984.
10. Cheung, K., and Lang, D. J. (1977). Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells. Infect. Immunol. 15, 568-575.
11. Coffman, R. L. (1982). Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69, 5-23.
12. Collins, T. M., Quirk, M. R., and Jordan, M. C. (1994). Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J. Virol. 68, 6305-6311.
13. Eron, J. J., Gorczyca, P., Kaplan, J. C., and D'Aquila, R. T. (1992). Susceptibility testing by polymerase chain reaction DNA quantitation: A method to measure drug resistance of human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 89, 3241-3245.
14. Fish, K. N., Depto, A. S., Moses, A. V., Britt, W., and Nelson, J. A. (1995). Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J. Virol. 69, 3737-3743.
15. Fish, K. N., Britt, W., and Nelson, J. A. (1996). A novel mechanism for persistence of human cytomegalovirus in macrophages. J. Virol. 70, 1855-1862.
16. Gibbons, A. E., Price, P., and Shellam, G. R. (1995). Analysis of hematopoietic stem and progenitor cell populations in cytomegalovirus-infected mice. Blood 86, 473-481.
17. Gnann, J. W., Ahlmen, J., Svalander, C., Olding, L., Oldstone, M. B. A., and Nelson, J. A. (1988). Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am. J. Pathol. 132, 239-248.
18. Heise, M. T., and Virgin, H. W. (1995). The T cell independent role of IFN-gamma and TNF-alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infection. J. Virol. 69, 904-909.
19. Henry, S. C., and Hamilton, J. D. (1993). Detection of murine cytomegalovirus immediate early transcripts in the spleens of latently infected mice. J. Infect. Dis. 167, 950-954.
20. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P., and Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179, 1713-1717.
21. Jordan, M. C., Shanley, J. D., and Stevens, J. G. (1977). Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J. Gen. Virol. 37, 419-423.
22. Jordan, M. C. (1980). Adverse effects of cytomegalovirus vaccination in mice. J. Clin. Invest. 65, 798-803.
23. Jordan, M. C., and Mar, V. L. (1982). Spontaneous activation of latent cytomegalovirus from murine spleen explants: Role of lymphocytes and macrophages in release and replication of virus. J. Clin. Invest. 70, 762-768.
24. Klotman, M. E., Henry, S. C., Greene, R. C., Brazy, P. C., Klotman, P. E., and Hamilton, J. D. (1990). Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. J. Infect. Dis. 161, 220-225.
25. Kondo, K., Kaneshima, H., and Mocarski, E. S. (1994). Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91, 11879-11883.
26. Koszinowski, U. H., Keil, G. M., Volkmer, H., Fibi, M. R., Ebeling Keil, A., and Munch, K. (1986). The 89,000-Mr murine cytomegalovirus immediate-early protein activates gene transcription. J. Virol. 58, 59-66.
27. Lewin, B. (1990). In "GENES IV" (B. Lewin, Ed.), pp. 466-481. Cell Press, Cambridge.
28. Maciejewski, J. P., Bruening, E. E., Donahue, R. E., Mocarski, E. S., Young, N. S., and St Jeor, S. C. (1992). Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80, 170-178.
29. Mayo, D., Armstrong, J. A., and Ho, M. (1978). Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression. J. Infect. Dis. 138, 890-896.
30. Mercer, J. A., Wiley, C. A., and Spector, D. H. (1988). Pathogenesis of murine cytomegalovirus infection: Identification of infected cells in the spleen during acute and latent infections. J. Virol. 62, 987-997.
31. Minton, E. J., Tysoe, C., Sinclair, J. H., and Sissons, J. P. G. (1994). Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68, 4017-4021.
32. Miyashita, E. M., Yang, B., Lam, K. M., Crawford, D. H., and Thorley-Lawson, D. A. (1995). A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80, 593-601.
33. Mocarski, E. S. (1996). In "Fields Virology" (B. N. Fields, D. M. Knipe, and P. M. Howley, Eds.), 3rd ed., pp. 2447-2492. Lippincott-Raven, Philadelphia.
34. Nelson, J. A., Gnann, J. W., and Ghazal, P. (1990). Regulation and tissue-specific expression of human cytomegalovirus. Curr. Top. Microbiol. Immunol. 154, 75-100.
35. Olding, L. B., Jensen, F. C., and Oldstone, M. B. (1975). Pathogenesis of cytomegalovirus infection I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogeneic reaction. J. Exp. Med. 141, 561-572.
36. Petursson, S. R., Chervenick, P. A., and Wu, B. (1984). Megakaryocytopoisis and granulopoiesis after murine cytomegalovirus infection. J. Lab. Clin. Med. 104, 381-390.
37. Pollock, J. L., and Virgin, H. W. (1995). Latency, without persistence, of murine cytomegalovirus in spleen and kidney. J. Virol. 69, 1762-1768.
38. Pomeroy, C., Hilleren, P. J., and Jordan, M. C. (1991). Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J. Virol. 65, 3330-3334.
39. Price, P., Winter, J. G., and Shellam, G. R. (1987). Genetically determined resistance to murine cytomegalovirus: A role for lymphocytostatic macrophages. J. Gen. Virol. 68, 2997-3008.
40. Saltzman, R. L., Quirk, M. R., and Jordan, M. C. (1988). Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J. Clin. Invest. 81, 75-81.
41. Shanley, J. D., Jordan, C., Cook, M. L., and Stevens, J. G. (1979). Pathogenesis of reactivated latent murine cytomegalovirus infection. Am. J. Pathol. 95, 67-80.
42. Simmons, P., Kaushansky, K., and Torok-Storb, B. (1990). Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 87, 1386-1390.
43. Sing, G. K., and Ruscetti, F. W. (1990). Preferential suppression of myelopoesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 75, 1965-1973.
44. Stoddart, C. A., Cardin, R. D., Boname, J. M., Manning, W. C., Abenes, G. B., and Mocarski, E. S. (1994). Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol. 68, 6243-6253.
45. Taylor-Wiedeman, J., Sissons, J. P. G., Borysiewicz, L. K., and Sinclair, J. H. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72, 2059-2064.
46. Taylor-Wiedeman, J., Sissons, P., and Sinclair, J. (1994). Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68, 1597-1604.
47. van Furth, R. (1970). Origin and kinetics of monocytes and macrophages. Semin. Hematol. 7, 125-141.
48. van Furth, R., and Cohn, Z. A. (1968). The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415-433.
49. Vieira, J., Farrell, H. E., Rawlinson, W. D., and Mocarski, E. S. (1994). Genes in the Hindlll J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: Insertional mutagenesis with a lacZ/gpt cassette. J. Virol. 68, 4837-4846.
50. Wilson, E. J., Medearis, D. N., Barrett, L. V., and Rubin, R. H. (1985). Activation of latent murine cytomegalovirus in cardiac explant and cell cultures. J. Infect. Dis. 152, 625-626.
51. Yu, Y., Henry, S. C., Xu, F., and Hamilton, J. D. (1995). Expression of a murine cytomegalovirus early-late protein in "latently" infected mice. J. Infect. Dis. 172, 371-379.
52. Yuhasz, S. A., Dissette, V. B., Cook, M. L., and Stevens, J. G. (1994). Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology 202, 272-280.
53. Zhu, H., Shen, Y., and Shenk, T. (1995). Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69, 7960-7970.